Arterial Occlusion Revealed by CT Angiography Predicts NIH Stroke Score and Acute Outcomes after IV tPA Treatment

References

1. ↵
   The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587

   CrossRefPubMedWeb of Science
2. ↵
   The NINDS t-PA stroke study group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109–2118

   Abstract/FREE Full Text
3. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). JAMA. 1995;274:1017–1025

   CrossRefPubMedWeb of Science
4. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study investigators. Lancet. 1998;352:1245–1251

   CrossRefPubMedWeb of Science
5. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: A randomized controlled trial. JAMA. 1999;282:2019–2026

   CrossRefPubMedWeb of Science
6. ↵
   Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA. 2000;283:1151–1158

   CrossRefPubMedWeb of Science
7. ↵
   Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA acute stroke study group. AJNR Am J Neuroradiol. 1993;14:3–13

   Abstract/FREE Full Text
8. ↵
   del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78–86

   CrossRefPubMedWeb of Science
9. ↵
   Heo JH, Kim SH, Lee KY, Kim EH, Chu CK, Nam JM. Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure. Stroke. 2003;34:48–50
10. ↵
    Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation. 2003;107:598–603

    Abstract/FREE Full Text
11. ↵
    Knauth M, von Kummer R, Jansen O, Hahnel S, Dorfler A, Sartor K. Potential of CT angiography in acute ischemic stroke. AJNR Am J Neuroradiol. 1997;18:1001–1010

    Abstract
12. ↵
    Lev MH, Farkas J, Rodriguez VR, et al. CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: Accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr. 2001;25:520–528

    CrossRefPubMed
13. ↵
    Shrier DA, Tanaka H, Numaguchi Y, Konno S, Patel U, Shibata D. CT angiography in the evaluation of acute stroke. AJNR Am J Neuroradiol. 1997;18:1011–1020

    Abstract
14. ↵
    Haley EC, Jr., Lewandowski C, Tilley BC. Myths regarding the NINDS rt-PA stroke trial: Setting the record straight. Ann Emerg Med. 1997;30:676–682

    PubMedWeb of Science
15. ↵
    Adams HP, Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35–41

    Abstract/FREE Full Text
16. ↵
    Koennecke HC, Nohr R, Leistner S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke. 2001;32:1074–1078

    Abstract/FREE Full Text
17. ↵
    Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The standard treatment with alteplase to reverse stroke (STARS) study. JAMA. 2000;283:1145–1150

    CrossRefPubMedWeb of Science
18. ↵
    Verro P, Tanenbaum LN, Borden NM, Sen S, Eshkar N. CT angiography in acute ischemic stroke: Preliminary results. Stroke. 2002;33:276–278

    Abstract/FREE Full Text
19. ↵
    Toni D, Fiorelli M, Bastianello S, et al. Acute ischemic strokes improving during the first 48 hours of onset: Predictability, outcome, and possible mechanisms. A comparison with early deteriorating strokes. Stroke. 1997;28:10–14

    Abstract/FREE Full Text
20. ↵
    Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke. 2002;33:2066–2071

    Abstract/FREE Full Text
21. ↵
    Kent DM, Ruthazer R, Selker HP. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke. 2003;34:464–467

    Abstract/FREE Full Text
22. ↵
    Cullen SP, Symons SP, Hunter G, et al. Dynamic contrast-enhanced computed tomography of acute ischemic stroke: CTA and CTP. Semin Roentgenol. 2002;37:192–205

    PubMed
23. Lev MH, Segal AZ, Farkas J, et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: Prediction of final infarct volume and clinical outcome. Stroke. 2001;32:2021–2028

    Abstract/FREE Full Text
24. ↵
    Wintermark M, Reichhart M, Thiran JP, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol. 2002;51:417–432

    CrossRefPubMedWeb of Science
25. ↵
    Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 1999;282:2003–2011

    CrossRefPubMedWeb of Science